The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
Open accessAbstract
Breast cancer affects approximately 12 % women worldwide and results in 14 % of all cancer-related fatalities. Breast cancer is commonly categorized into one of four main subtypes (luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) positive and basal), indicating molecular characteristics and informing treatment regimes. The most severe form of breast cancer is metastasis, when the tumour spreads from the breast tissue to other parts of the body. Significantly, the primary tumour subtype affects rates and sites of metastasis. Currently, up to 5 % of patients present with incurable metastasis, with an additional 10-15 % of patients going on to develop metastasis within 3 years of diagnosis. MicroRNAs (miRNAs) are short 21-25 long nucleotides that have been shown to significantly affect gene expression. Currently, >2000 miRNAs have been identified and significantly, specific miRNAs have been found associated with diseases states. Importantly, miRNAs are found circulating in the blood, presenting an opportunity to use these circulating disease-related miRNAs as biomarkers. Clearly, the identification of circulating miRNA specific to metastatic breast cancer presents a unique opportunity for early disease identification and for monitoring disease burden. Currently however, few groups have identified miRNA associated with metastatic breast cancer. Here, we review the literature surrounding the identification of metastatic miRNA in breast cancer patients, highlighting key areas where miRNA biomarker discovery could be beneficial, identifying key concepts, recognizing critical areas requiring further research and discussing potential problems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szász, A. M., Wang, Z. C., Brock, J. E., Richardson, A. L., & Weinberg, R. A. (2009) · Cell · doi:10.1016/j.cell.2009.03.047 · Cited by 820
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“1 months [89].”
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
CA: A Cancer Journal for Clinicians
(2010) · CA A Cancer Journal for Clinicians · doi:10.3322/(issn)1542-4863 · Cited by 2,538
Metastatic Behavior of Breast Cancer Subtypes
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O., & Gelmon, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9820 · Cited by 2,262
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
Bauer, K. R., Brown, M., Cress, R. D., Parise, C. A., & Caggiano, V. (2007) · Cancer · doi:10.1002/cncr.22618 · Cited by 2,067
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Barnholtz-Sloan, J. S., Sloan, A. E., Davis, F. G., Vigneau, F. D., Lai, P., & Sawaya, R. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.149 · Cited by 1,843
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07077.x · Cited by 1,735
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476
miRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329
Lumeij, J. T. (1997) · Clinical Biochemistry of Domestic Animals · doi:10.1016/b978-012396305-5/50031-2 · Cited by 1,163
Yan, L.-X., Huang, X.-F., Shao, Q., Huang, M.-Y., Deng, L., Wu, Q.-L., Zeng, Y.-X., & Shao, J.-Y. (2008) · RNA · doi:10.1261/rna.1034808 · Cited by 1,148
Lujambio, A., & Lowe, S. W. (2012) · Nature · doi:10.1038/nature10888 · Cited by 1,084
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., Egan, D. A., Li, A., Huang, G., Klein-Szanto, A. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1681 · Cited by 975
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S.-F., Dunning, M. J., Barbosa-Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-10-r214 · Cited by 948
Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E., & Okunieff, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321402 · Cited by 892 · cited 1×
“However, the use of chemotherapy, radiotherapy and hormone therapy has vastly improved survival rates [81–83].”
BackgroundSubtypes of Breast Cancer Show Preferential Site of Relapse
Smid, M., Wang, Y., Zhang, Y., Sieuwerts, A. M., Yu, J., Klijn, J. G. M., Foekens, J. A., & Martens, J. W. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5644 · Cited by 813
Onitilo, A. A., Engel, J. M., Greenlee, R. T., & Mukesh, B. N. (2009) · Clinical Medicine & Research · doi:10.3121/cmr.2008.825 · Cited by 765
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
Kent, O. A., & Mendell, J. T. (2006) · Oncogene · doi:10.1038/sj.onc.1209913 · Cited by 720
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Heneghan, H. M., Miller, N., Lowery, A. J., Sweeney, K. J., Newell, J., & Kerin, M. J. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181cc939f · Cited by 687
Self-citationFyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M., & Olivotto, I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040595 · Cited by 651
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
Eroles, P., Bosch, A., Alejandro Pérez-Fidalgo, J., & Lluch, A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.005 · Cited by 624
Beyond tumorigenesis: cancer stem cells in metastasis
Li, F., Tiede, B., Massagué, J., & Kang, Y. (2007) · Cell Research · doi:10.1038/sj.cr.7310118 · Cited by 620
Gianni, L., Dafni, U., Gelber, R. D., Azambuja, E., Muehlbauer, S., Goldhirsch, A., Untch, M., Smith, I., Baselga, J., Jackisch, C., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70033-x · Cited by 612
MicroRNAs: Novel Biomarkers for Human Cancer
Bartels, C. L., & Tsongalis, G. J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112805 · Cited by 529
Song, S. J., Poliseno, L., Song, M. S., Ala, U., Webster, K., Ng, C., Beringer, G., Brikbak, N. J., Yuan, X., Cantley, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.026 · Cited by 491
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
Baffa, R., Fassan, M., Volinia, S., O'Hara, B., Liu, C., Palazzo, J. P., Gardiman, M., Rugge, M., Gomella, L. G., Croce, C. M., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2586 · Cited by 473
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Asaga, S., Kuo, C., Nguyen, T., Terpenning, M., Giuliano, A. E., & Hoon, D. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.151845 · Cited by 451
Lowery, A. J., Miller, N., Devaney, A., McNeill, R. E., Davoren, P. A., Lemetre, C., Benes, V., Schmidt, S., Blake, J., Ball, G., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2257 · Cited by 450
Self-citationCirculating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K., & Schwarzenbach, H. (2010) · Breast Cancer Research · doi:10.1186/bcr2766 · Cited by 430
De Laurentiis, M., Cancello, G., D'Agostino, D., Giuliano, M., Giordano, A., Montagna, E., Lauria, R., Forestieri, V., Esposito, A., Silvestro, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3787 · Cited by 416
Hubbard, R. A., Kerlikowske, K., Flowers, C. I., Yankaskas, B. C., Zhu, W., & Miglioretti, D. L. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00004 · Cited by 414
Smith, T. J., & Khatcheressian, J. L. (2005) · Cited by 401
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
Lowery, A. J., Kell, M. R., Glynn, R. W., Kerin, M. J., & Sweeney, K. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1891-6 · Cited by 389
Self-citationMicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
Farazi, T. A., Horlings, H. M., ten Hoeve, J. J., Mihailovic, A., Halfwerk, H., Morozov, P., Brown, M., Hafner, M., Reyal, F., van Kouwenhove, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0608 · Cited by 346
miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
Enerly, E., Steinfeld, I., Kleivi, K., Leivonen, S.-K., Aure, M. R., Russnes, H. G., Rønneberg, J. A., Johnsen, H., Navon, R., Rødland, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016915 · Cited by 310
Hunter, K. W., Crawford, N. P., & Alsarraj, J. (2008) · Breast Cancer Research · doi:10.1186/bcr1988 · Cited by 298
Toiyama, Y., Hur, K., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2014) · Annals of Surgery · doi:10.1097/sla.0b013e3182a6909d · Cited by 294
(1926) · The American Journal of Surgery · doi:10.1016/s0002-9610(26)90068-8 · Cited by 293
Jung, E., Santarpia, L., Kim, J., Esteva, F. J., Moretti, E., Buzdar, A. U., Di Leo, A., Le, X., Bast, R. C., Park, S., et al. (2012) · Cancer · doi:10.1002/cncr.26565 · Cited by 292
Delivering the promise of miRNA cancer therapeutics
Pereira, D. M., Rodrigues, P. M., Borralho, P. M., & Rodrigues, C. M. P. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.002 · Cited by 288
Bosch, A., Eroles, P., Zaragoza, R., Viña, J. R., & Lluch, A. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.12.002 · Cited by 283
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Wang, H., Tan, G., Dong, L., Cheng, L., Li, K., Wang, Z., & Luo, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034210 · Cited by 275
MicroRNA control of epithelial–mesenchymal transition and metastasis
Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273
Madhavan, D., Zucknick, M., Wallwiener, M., Cuk, K., Modugno, C., Scharpff, M., Schott, S., Heil, J., Turchinovich, A., Yang, R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1407 · Cited by 249
Nguyen, H. C. N., Xie, W., Yang, M., Hsieh, C., Drouin, S., Lee, G. M., & Kantoff, P. W. (2013) · The Prostate · doi:10.1002/pros.22572 · Cited by 245
Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer
Sun, Y., Wang, M., Lin, G., Sun, S., Li, X., Qi, J., & Li, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047003 · Cited by 239
Sihto, H., Lundin, J., Lundin, M., Lehtimäki, T., Ristimäki, A., Holli, K., Sailas, L., Kataja, V., Turpeenniemi-Hujanen, T., Isola, J., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2944 · Cited by 229
MicroRNAs and Metastasis: Little RNAs Go a Long Way
Dykxhoorn, D. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1346 · Cited by 210
Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis
Wang, L.-G., & Gu, J. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2011.05.002 · Cited by 199
Eichelser, C., Flesch-Janys, D., Chang-Claude, J., Pantel, K., & Schwarzenbach, H. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.205161 · Cited by 195
van Schooneveld, E., Wouters, M. C., Van der Auwera, I., Peeters, D. J., Wildiers, H., Van Dam, P. A., Vergote, I., Vermeulen, P. B., Dirix, L. Y., & Van Laere, S. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3127 · Cited by 191
Berman, A. T., Thukral, A. D., Hwang, W.-T., Solin, L. J., & Vapiwala, N. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.11.001 · Cited by 180
Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
Cascione, L., Gasparini, P., Lovat, F., Carasi, S., Pulvirenti, A., Ferro, A., Alder, H., He, G., Vecchione, A., Croce, C. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055910 · Cited by 179
Chen, W., Cai, F., Zhang, B., Barekati, Z., & Zhong, X. Y. (2013) · Tumor Biology · doi:10.1007/s13277-012-0570-5 · Cited by 177
Munker, R., & Calin, G. A. (2011) · Clinical Science · doi:10.1042/cs20110005 · Cited by 174
Cuiffo, B. G., Campagne, A., Bell, G. W., Lembo, A., Orso, F., Lien, E. C., Bhasin, M. K., Raimo, M., Hanson, S. E., Marusyk, A., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.10.001 · Cited by 173
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients
Schwarzenbach, H., Milde‐Langosch, K., Steinbach, B., Müller, V., & Pantel, K. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1988-6 · Cited by 162
Ihemelandu, C. U., Leffall, L. D., Dewitty, R. L., Naab, T. J., Mezghebe, H. M., Makambi, K. H., Adams-Campbell, L., & Frederick, W. A. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.03.085 · Cited by 159
Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
Chen, J., Tian, W., Cai, H., He, H., & Deng, Y. (2011) · Medical Oncology · doi:10.1007/s12032-011-0117-4 · Cited by 158
Kjersem, J. B., Ikdahl, T., Lingjærde, O. C., Guren, T. K., Tveit, K. M., & Kure, E. H. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.09.001 · Cited by 157
Volinia, S., & Croce, C. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304977110 · Cited by 149
Gasparini, P., Cascione, L., Fassan, M., Lovat, F., Güler, G., Balcı, S., Irkkan, Ç., Morris, Q., Croce, C. M., Shapiro, C. L., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1682 · Cited by 148
The Emerging Role of Exosomes in Epithelial–Mesenchymal-Transition in Cancer
Vella, L. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00361 · Cited by 147
Gonzales, J. C., Fink, L. M., Goodman, O. B., Symanowski, J. T., Vogelzang, N. J., & Ward, D. C. (2011) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2011.05.008 · Cited by 139
Metastatic breast cancer subtypes and central nervous system metastases
Aversa, C., Rossi, V., Geuna, E., Martinello, R., Milani, A., Redana, S., Valabrega, G., Aglietta, M., & Montemurro, F. (2014) · The Breast · doi:10.1016/j.breast.2014.06.009 · Cited by 136
Chen, J., Yao, D., Li, Y., Chen, H., He, C., Ding, N., Lü, Y., Ou, T., Zhao, S., Li, L., et al. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1424 · Cited by 134
Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis
Shi, M., Liu, D., Duan, H., Shen, B., & Guo, N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9265-9 · Cited by 118
Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
McDermott, A. M., Miller, N., Wall, D., Martyn, L. M., Ball, G., Sweeney, K., & Kerin, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087032 · Cited by 117
Self-citationMicroRNA-mediated breast cancer metastasis: from primary site to distant organs
Wang, L., & Wang, J. (2011) · Oncogene · doi:10.1038/onc.2011.444 · Cited by 114
Markou, A. N., Yousef, G. M., Stathopoulos, E. N., Georgoulias, V., & Lianidou, E. S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210542 · Cited by 106
Toyama, T., Kondo, N., Endo, Y., Sugiura, H., Yoshimoto, N., Iwasa, M., Takahashi, S., Fujii, Y., & Yamashita, H. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys001 · Cited by 96
Hoppe, R., Achinger-Kawecka, J., Winter, S., Fritz, P., Lo, W., Schroth, W., & Brauch, H. B. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.145 · Cited by 95
Anfossi, S., Giordano, A., Gao, H., Cohen, E. N., Tin, S., Wu, Q., Garza, R. J., Debeb, B. G., Álvarez, R. H., Valero, V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083113 · Cited by 95
miR-429 inhibits migration and invasion of breast cancer cells in vitro
Ye, Z., Ma, G., Zhao, Y., Xiao, Y., Zhan, Y., Jing, C., Gao, K., Liu, Z., & Yu, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2759 · Cited by 94
MicroRNAs and Metastasis-related Gene Expression in Egyptian Breast Cancer Patients
Hafez, M. M., Hassan, Z. K., Zekri, A. N., Gaber, A. A., Rejaie, S. S. A., Sayed‐Ahmed, M. M., & Shabanah, O. A. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.2.591 · Cited by 91
Avery‐Kiejda, K. A., Braye, S. G., Mathe, A., Forbes, J., & Scott, R. J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-51 · Cited by 91
Validation of Circulating miRNA Biomarkers for Predicting Lymph Node Metastasis in Gastric Cancer
Kim, S. Y., Jeon, T. Y., Choi, C. I., Kim, D. H., Kim, D. H., Kim, G. H., Ryu, D. Y., Lee, B. E., & Kim, H. H. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.04.004 · Cited by 86
Zhao, S., Yao, D., Chen, J., & Ding, N. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2013.0085 · Cited by 86
Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer
Zhao, F.-L., Hu, G.-D., Wang, X., Zhang, X.-H., Zhang, Y.-K., & Yu, Z.-S. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000304 · Cited by 85
Rask, L., Balslev, E., Søkilde, R., Høgdall, E. V. S., Flyger, H., Eriksen, J., & Litman, T. (2014) · Cellular Oncology · doi:10.1007/s13402-014-0176-6 · Cited by 78
Zhang, H.-L., Qin, X.-J., Cao, D., Zhu, Y., Yao, X.-D., Zhang, S.-L., Dai, B., & Ye, D. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2012.116 · Cited by 76
Dai, X., Chen, A., & Bai, Z. (2014) · Scientific Reports · doi:10.1038/srep06566 · Cited by 73
A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
Shen, S., Sun, Q., Liang, Z., Cui, X., Ren, X., Chen, H., Zhang, X., & Zhou, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100664 · Cited by 72
Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis.
Ahmad, A., Sethi, S. N., Chen, W., Ali‐Fehmi, R., Mittal, S., & Sarkar, F. H. (2014) · PubMed Central · Cited by 67
Biologic profiling of lymph node negative breast cancers by means of microRNA expression
Janssen, E. A. M., Slewa, A., Gudlaugsson, E. G., Jónsdóttir, K., Skaland, I., Søiland, H., & Baak, J. P. A. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.177 · Cited by 65
Are RNAi and miRNA therapeutics truly dead?
Conde, J., & Artzi, N. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.12.005 · Cited by 63
RNAi Therapeutics and Applications of MicroRNAs in Cancer Treatment
Uchino, K., Ochiya, T., & Takeshita, F. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt052 · Cited by 63
Prognostic factors in patients with metastatic breast cancer at the time of diagnosis
Ren, Z., Li, Y., Hameed, O. M., Siegal, G. P., & Wei, S. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.01.008 · Cited by 61
Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs
Shivapurkar, N., Weiner, L. M., Marshall, J. L., Madhavan, S., Mays, A. D., Juhl, H. H., & Wellstein, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084686 · Cited by 61
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
Christodoulatos, G. S. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i2.71 · Cited by 55
A summary for molecular regulations of miRNAs in breast cancer
Yahya, S. M. M., & Elsayed, G. H. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.12.013 · Cited by 54
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR‐34a and miR‐122 Expression
Frères, P., Josse, C., Bovy, N., Boukerroucha, M., Struman, I., Bours, V., & Jérusalem, G. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24730 · Cited by 52
Smeets, A., Daemen, A., Bempt, I. V., Gevaert, O., Claes, B., Wildiers, H. P. M. W., Drijkoningen, R., Hummelen, P. V., Lambrechts, D., Moor, B. D., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1265-5 · Cited by 41
Gene-expression assays: New tools to individualize treatment of early-stage breast cancer
Dobbe, E., Gurney, K., Kiekow, S., Lafferty, J. S., & Kolesar, J. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060352 · Cited by 34
Hide and seek: tell-tale signs of breast cancer lurking in the blood
Guttery, D. S., Blighe, K., Page, K., Marchese, S. D., Hills, A., Coombes, R. C., Stebbing, J., & Shaw, J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9414-4 · Cited by 21
microRNA-210 as a prognostic factor in patients with breast cancer: Meta-analysis
Li, Y., Ma, X., Zhao, J., Zhang, B., Zhang, J., & Liu, L. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130385 · Cited by 19
(2003) · PubMed
Cited by
Tumor microenvironment differences between primary tumor and brain metastases
Cacho-Díaz, B., García-Botello, D. R., Wegman-Ostrosky, T., Reyes-Soto, G., Ortiz-Sánchez, E., & Herrera-Montalvo, L. A. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-019-02189-8 · Cited by 310
Luo, K., Gao, Y., Yin, S., Yao, Y., Yu, H., Wang, G., & Li, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.07.029 · Cited by 70
Metadata
- Authors
- McGuire, A., Brown, J. A. L., & Kerin, M. J.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2015-02-27
- Volume
- 34
- Issue
- 1
- Pages
- 145-155
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2030487571
- Cited by
- 329
- References
- 121
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.